Response from: Technical Support    (09/28/06 7:37am)

This is booming period for biotechnology, the Indian Government also emphasise on strategic research and development in biotechnology. The Ernst & Young reports that revenues reached an all-time high last year of $63.1 billion, this is really encouraging figure. Cheers!

Response from: y    (10/04/06 2:14pm)

Seed capital is really not the greatest hurdle for outsourcing in India. There are plenty of academic labs and established firms that are well positioned for contracting. The central role of intellectual property in biotechnology is at odds with India's traditionally lax IP laws (which have recently been tightned). It is yet to bee seen how strongly India's new IP rules will be enforced. Furthermore, there's also the issue of being able to manage projects from half a world away and to ensure appropriate communication of processes and endpoints. Biotechnology has traditionally benefitted greatly from having researchers in great proximity to each other.

Response from: BGRC    (08/20/08 11:45pm)

its going to be a booming time for biotechnology ahead but we have to make our professionals ready for international competetion, we in our labs are on that mission. any outsourcing research works are welcomed send your enquires to biogenixresearchcenter@gmail.com